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Abstract
Animal models of dengue virus disease have been very difficult to develop because of the virus’ specificity for infection and
replication in certain human cells. We developed a model of dengue fever in immunodeficient mice transplanted with
human stem cells from umbilical cord blood. These mice show measurable signs of dengue disease as in humans (fever,
viremia, erythema and thrombocytopenia), and after infection with the most virulent strain of dengue serotype 2,
humanized mice showed infection in human cells in bone marrow, spleen and blood. Cytokines and chemokines were
secreted by these human cells into the mouse bloodstream. We demonstrated that the pathology of dengue virus infection
in these mice follows that reported in human patients, making this the first valid and relevant model for studying dengue
fever pathogenesis in humans.
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Introduction
Dengue has become the most important mosquito-transmitted
virus to human health since it is now endemic in over 100
countries and infects over 50 million persons per year. Dengue
viruses, of which there are 4 antigenic types or serotypes, cause
dengue fever (DF), a self-limiting, influenza-like illness with rash,
or dengue hemorrhagic fever (DHF), a much more severe disease,
with bleeding abnormalities that can lead to death. The large
majority of human cases present with DF, some with minor
bleeding abnormalities, and about 1% of patients, mainly children,
go on to develop DHF and require hospitalization [1]. However,
little is known about the mechanisms of dengue pathogenesis and
there are no treatments nor prophylaxis for dengue infection;
currently, the only method of disease control is mosquito
abatement. Most of what is known about dengue disease
progression comes from observational studies in human patients
because there are no other hosts of this virus. Studies done in the
early 20th century demonstrated that when a broad range of
animals were inoculated with dengue virus, none of them became
ill nor had high levels of virus in their blood (for a review see [2]).
Thus, we have not had an animal model of disease in which to
study the details of disease progression, and what we know to date
is that human host and viral genetics are determinants of disease
and that prior immunity to one serotype increases the probability
of developing DHF. That is, antibodies or memory T cells to one
virus may cause severe, hemorrhagic manifestations during a
subsequent, heterologous virus infection, referred to as immune
enhancement of disease [3,4]. This phenomenon makes the study
of dengue virus pathogenesis even more complex, given the fact
that there are 4 dengue serotypes and a wide variety of genetic
differences between strains within each serotype [5].
Immunodeficient mouse strains that have been transplanted
with human stem cells (from umbilical cord blood or fetal cells)
have been shown to develop functional human immune systems,
including some level of adaptive immunity [6]. It has been
reported that some of these mouse strains develop immunoglob-
ulins specific for human immunodeficiency virus and dengue
virus, albeit at low levels, after experimental infection [7,8]. Only
one humanized mouse model, receiving human fetal stem cells,
has reportedly produced specific antibodies to dengue viruses
after simultaneous infection with multiple strains of virus [9]. In
contrast, we were the first to present results of dengue virus
pathogenesis studies in the NOD/SCID mouse strain [10], and
later, in the NOD-scid IL2Rc mouse strain that has a higher
degree of human lymphocyte development (median of 52%
engrafment in blood) but after transplantation with human cord
blood stem cells only [11]. We compared viruses from different
genetic subgroups (genotypes) of dengue serotype 2 (DEN-2) and
showed that there were significant differences in mouse clinical
signs that correlated with infection by each of the 4 genotypes.
Thus, we developed a measure of virulence in an animal model, a
first for dengue, and these mice consistently present with signs of
dengue fever as in humans. However, these mice do not develop
specific antibodies to these viruses, and this is probably why they
do not develop more severe disease, such as human-like DHF. In
this report we present results of an in depth analysis of the
pathology and tropism of dengue virus infection in the same
strain of mice, using one strain of dengue virus serotype 2
(K0049, Southeast Asian genotype). A total of 27 humanized
mice were infected and sacrificed during different time points
after infection (9 independent experiments with n=3 each), to
define the dynamics of dengue virus replication and tropism in
this mouse model of DF.
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Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the Southwest Foundation for Biomedical Research
(Protocol Number: 1054 MU). All procedures were performed
under isofluorane deep anesthesia, and all efforts were made to
minimize suffering.
Mice and transplantation
We established a colony of NOD.Cg-Prkdc
scid IL2rg
tm1Wjl/SzJ
(NSG mice) from breeding pairs obtained from The Jackson
Laboratory (Maine), housed in a specific pathogen-free facility
under sterile conditions. Animal manipulation and procedures
were as described previously [11]. For transplantation, human
cord bloods from anonymous donors were obtained from the
South Texas Blood and Tissue Center (San Antonio, Texas) and
peripheral blood mononuclear cells (PBMCs) were separated out
by Ficoll-Hypaque density gradient followed by positive selection
of CD34
+ hematopoietic stem cells using a CD34
+ Progenitor Cell
Selection System (Invitrogen) according to the manufacturer’s
instructions. We used flow cytometry analysis (described below) to
confirm purity, which usually ranged from 85 to 90%. In
preparation for transplantation, newborn mice were transported
in microisolation irradiator cages (Braintree Scientific) to the
University of Texas Health Sciences Center facilities (San Antonio,
Texas) and sub-lethally irradiated with 100 cGy using a Cesium
source. Mice were then transplanted by intrahepatic inoculation of
3610
5 purified cord blood CD34
+ cells. Mouse irradiation and
transplantation procedures occurred 24–48 hrs after birth.
Dengue virus preparation
Low passage dengue virus serotype 2, strain K0049 was used in
this study. Viral stocks were prepared as described previously [11].
Briefly, confluent monolayers of the C6/36 (Aedes albopictus) grown
in 75 cm
2 flasks were infected with dengue virus at a multiplicity of
about 10 genome equivalents (0.01 PFU) per cell and incubated
1 hour at 28uC with 5% CO2, after one wash, fresh medium was
added and incubated for 7–9 days, until infection occurred in
more than 90% of the cells as evidenced by indirect fluorescent
antibody (IFA) assay, using mouse hyperimmune ascitic fluid of
MAb 3H5, against DEN-2, specifically the E protein (CDC, Fort
Collins, CO). Cell supernatants were harvested and stabilized by
adding 30% (v/v) of a 2% gelatin solution (Sigma); 0.5–1.0 mL
aliquots were prepared and stored at 270uC until use.
Concentration in genome equivalents per mL (gEq/mL) was
measured by real time quantitative RT-PCR and usually ranged
from 1610
9 to 1610
10 gEq/mL. Only fresh, unthawed aliquots
were used in all experiments.
Flow cytometry
Purity of enriched CD34
+ cells from cord blood was evaluated
by flow cytometry, by staining cells with PE-conjugated anti-
human CD34 (clone 563) antibody (BD-Biosciences), which is
different from that used on beads for positive selection. To
evaluate the presence of human cells in peripheral blood or mouse
tissues, the following anti-human antibodies were used: CD45-
APC, CD45-V500, CD3-Pac Blue, CD8-PerCP.Cy5.5, HLA-DR-
PerCP (BD-Biosciences), CD16-Alexa Fluor 700, CD45-FITC
(Invitrogen), CD20-FITC, CD14-PE (Beckman Coulter), and
CD19-Alexa700 (Biolegend). To test engraftment levels 6 weeks
after transplantation, 50 ml of blood was collected by the retro-
orbital route using calibrated capillary micropipettes (Drummond);
blood was deposited in heparinized collection tubes (Braintree
Scientific) and stained with the antibodies listed above. Red blood
cells were lysed with 16Red Blood Cell Lysis Solution (Miltenyi),
washed twice in PBS, fixed with 1.6% methanol-free formalde-
hyde and processed for flow cytometry analysis. To analyze
human infected cells in different mouse tissues, blood, liver, lymph
node, spleen and bone marrow (obtained by flushing the mouse
femurs with RPMI supplemented with 10% of FBS) were obtained
at different time points and single cell suspensions prepared by
passing the cells through 100 mM cell strainers (BD-Biosciences).
These cells then were counted using trypan blue, and one million
used for surface staining with the antibodies listed above. For
intracellular staining, cells were fixed and permeabilized with
Cytofix/Cytoperm solution (BD-Biosciences) and stained for
dengue antigen with MAb 2H2 (anti-prM gene) coupled to FITC
[12]. Isotype-matched antibodies were used for appropriate
surface and intracellular controls. Samples were acquired using a
CyAn ADP analyzer and data were analyzed using Summit
software (Beckman Coulter).
Mouse infection and clinical sign monitoring
Adult mice (6–8 weeks) with engraftment levels of 17–89% were
used to make experimental groups of 3 individuals each for
infection experiments with DEN-2 virus. Viral stock was diluted
with sterile PBS, to a concentration of 9 log10 genome equivalents
(about 6 log10 PFU) in a final volume of 100 ml, and mice were
inoculated intradermally on the back, while under isofluorane
anesthesia. Mock-infected groups were inoculated with the same
amount of C6/36 cell culture media prepared with 30% gelatin
(v/v), as in the virus stock, and diluted in PBS. Mouse temperature
and erythema were measured at the specified intervals (daily,
initially, and on alternate days, later) and platelets were measured
in infected and control mice at day 10 p.i. For temperature
measurements we used a RET-3 rectal probe coupled to a BAT-12
Microprobe Thermometer (Physitemp Instruments), and erythema
was measured using a DSMII ColorMeter (Cortex Technology,
Denmark), as previously described [10,11]. Viremia was measured
in 10 ml of sera (from 25 ml of peripheral blood, obtained retro-
orbitally) at the specified intervals, starting at day 1 p.i.
Quantitative RT-PCR
RNA copies in viral stocks or in sera obtained from infected
mice were measured as previously reported [11]. Briefly, the RNA
template (5 ml of viral stock or 10 ml of serum) was amplified in
duplicate or triplicate (sera or viral stock, respectively) using the
RNA Ultrasense, One-step Quantitative RT-PCR System (Invi-
trogen), with the forward and reverse primers: d2C16A (59-
GCTGAAACGCGAGAGAAACC-39), d2C46B (59-CAGTTT-
TAITGGTCCTCGTCCCT-39), and the VICd2C38B probe
(FAM-59-AGCATTCCAAGTGAGAATCTCTTTGTCAGCT-
GT-39-TAMRA). This protocol amplifies a 94 bp fragment of a
highly conserved region of the capsid gene of DEN-2 viruses and
efficiently detects dengue virus in peripheral blood mononuclear
cells from human clinical samples [13]. To estimate RNA copies,
a standard curve was generated using 10-fold serial dilutions of in
vitro transcribed RNA standards [14]. The sensitivity of the assay
is 240 RNA copies per ml or 1.2 copies per reaction tube.
Dengue ELISA
To determine the presence of human antibodies (total im-
munoglobulins) against DEN- 2 in the sera of humanized mice, we
used an indirect ELISA as previously described [11]. Serum
Dengue Virus Tropism in Humanized Mice
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described above at different time points, serially diluted starting
at 1:20, and tested in duplicates. The cutoff to consider a sample
positive was the average of the O.D. of negative controls plus one
standard deviation.
Cytokine Production
Human cytokines and chemokines were measured in the sera of
infected and control humanized mice by means of multiplex
analysis, with fluorescently-labeled microsphere beads in a
Luminex platform. A panel of nine human cytokines and
chemokines, TNF-a, IFN-c, IL-2, sIL-2R, IL-6, IL-8, IL-10,
MCP-1 and VEGF, were tested using the premixed Milliplex
MPXHCYTO-60K kit (Millipore) according to the manufactur-
er’s instructions. At different time points, serum samples from
infected and control mice were obtained as described above,
diluted 1:1 and tested in duplicates using the Luminex 100 system
(Luminex Co.), and the MasterPlex QT v4.0 software (MiraBio).
Results were expressed in picograms per milliliter (pg/mL) and the
average background of control samples was subtracted from results
of infected mice.
Histopathology
Liver, lymph node, spleen and femurs (for bone marrow
staining) were collected at different time points and either
embedded in optimal cutting temperature compound (OCT) and
snap-frozen, or fixed in 10% neutral buffered formalin and
embedded in paraffin. Frozen tissues were cut in 6 mM sections,
fixed with 4% formaldehyde and permeabilized with 0.25%
Triton X-100 in PBS. Sections were stained for human
lymphocytes with an anti-human CD45-FITC (Invitrogen) diluted
1:100 and for dengue virus using the anti-DEN-2 3H5 (anti-E
protein) MAb (diluted 1:200) as primary antibody, followed by
Alexa Fluor-594 goat anti-mouse IgG (Invitrogen) as secondary
antibody (diluted 1:200). Slides were mounted using the ProLong
Gold Antifade reagent with DAPI (Invitrogen). For paraffin-fixed
tissues, 6 mM sections were prepared and after deparaffinization,
antigen retrieval was carried out using a standard citrate protocol
followed by permeabilization, staining with anti-human and
anti-dengue antibodies, and mounted as described above. Slides
were observed with a Nikon Eclipse TE2000-U microscope, and
images were acquired and processed using a Nikon DS-Ri1 camera
and the NIS-Elements Microscope Imaging Software (Nikon),
respectively.
Statistical analyses
For comparison of erythema index, temperature, and platelet
measurements in infected and control humanized mice groups, a t
test analysis was performed using GraphPad Prism v5.0.
Results
Infection and clinical signs in humanized mice
Groups of humanized mice with engraftment levels ranging
from 17 to 89% (percent of human CD45+ cells) were used in
infection experiments as described previously [11]. We used the
low passage DEN-2 strain K0049 (Southeast Asian genotype) for
these infections, as we previously demonstrated that this strain has
the most virulent phenotype [11]. Infected mice were followed for
a period of up to 18 days post infection (p.i.) and clinical signs of
infection were recorded at variable intervals (days 1, 2, 3, 4, 6, 8,
10, 14, and 18) before mice were euthanized. Our previous studies
showed that dengue virus RNA was no longer detected on days
20–22 p.i. [11], so we decided to sacrifice mice at the latest on day
18 p.i., in order to detect infected cells before the viremia ended.
Viremia was measured in sera of infected mice and the results
showed a two-peak distribution as we observed previously [11],
with one peak on day 3 p.i. and the second and highest around day
18 (Fig. 1A, upper panel). Human cell engraftment levels do not
seem to influence the replication of this virus, since high viremia
was observed even in experimental groups with low engraftment
levels (day 10 p.i. Fig. 1A, lower panel). Because the mean of 3
mice is plotted for each day, only on day 1 p.i. the mean value
dropped below the limit of detection. Mock-inoculated controls
(media only) were always negative in the qRT-PCR. Infected mice
also showed an increase in erythema index by day 3 p.i., peaking
at days 6–8 and decreasing by day 18 (Fig. 1B) in accordance with
our previous observations. In the case of fever, infected mice
showed an increase in body temperature on the first day of
infection, with small variations of about one degree Celsius along
the time course (Fig. 1C), similar to what we previously observed
[11]. In addition, we noted a significant reduction in the number
of platelets in the infected mice at day 10 p.i. (Fig. 1D), an optimal
time point for this measurement, based on our previous studies
[11]. All clinical signs observed in the infected, humanized mice
were statistically significant when compared with the mock-
inoculated control groups.
Infection with dengue occurs in human cells, in different
mouse tissues
To study dengue virus tropism in the humanized mouse model,
we analyzed the presence of dengue-infected cells in different
tissues, at different days post infection. We collected blood, liver,
lymph nodes, spleen and bone marrow from infected and control
mice to identify the human cells that become infected and support
dengue virus replication. We attempted to analyze replication in
the liver, but no infected cells were found on any of the days tested
(data not shown); we suspect that this is due to the lack of human
hepatocytes in these mice. Since lymph nodes are absent or
defective in the NSG mice, the tissues that were dissected in this
area showed no consistent results and were not included here.
We analyzed infected cells by means of immunofluorescence
(IF) and flow cytometry assays. In the IF experiments, we first
confirmed tissue architecture in the spleen and bone marrow by
staining the tissue sections (5 mM) with hematoxylin and eosin;
results showed a normal cell distribution and architecture in both
tissues (Fig. 2A–H). Tissue sections were double stained for
human CD45 positive cells (green) and for dengue virus serotype 2
(red), as described in Materials and Methods. For the spleen
(Fig. 2I–L), we observed that during the first days of infection
(Fig. 2I), double stained cells are dispersed outside the follicle-like
structures (FLSs), while by day 10 p.i., intense double stained cells
(orange-yellow color) are found inside the FLSs (Fig. 2J and 2P),
which are mainly formed by B and T lymphocytes [7]. Later, at
days 14 and 18 p.i, less intense staining double positive cells were
observed, and most of the dengue positive cells appeared to be
outside the FLSs. Similarly, for bone marrow (Fig. 2M–P)w e
observed positive cells for dengue antigen in leukocyte-rich areas,
with more intense staining in cells located close to the central vein
(Fig. 2O and 2R). Double positive cells increased in number by
day 14 p.i and were still detectable by day 18. Stained sections
from control mice showed only CD45+ cells and low background
with the anti-E protein dengue antibody (Fig. 2S–T).
For a finer identification of human cells infected by dengue virus
in these mice, we performed flow cytometry analysis of the same
tissues used in the IF analysis, but using antibodies against human
B cells (CD19), T cells (CD3), monocytes/macrophages (CD14)
and the general leukocyte marker CD45, in addition to an anti-
Dengue Virus Tropism in Humanized Mice
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analyzed in the lymphocyte gate defined as the region of forward
and side scatter with the highest number of human CD45+ cells
(Figures S1, S2, S3, S4, S5, S6, S7, S8, S9; one example per time
point). The percent of infected cells for each specific lymphocyte
subpopulation was obtained by dividing the number of dengue
positive cells by the total number of cells in the lymphocyte
subpopulation gate, and then multiplied by 100. Plotted results are
the mean of results from 3 mice in each of 9 experimental groups,
with the standard deviation of the mean (SEM) indicated also.
Background staining obtained in mock-inoculated control mice
was subtracted from values for infected mice. Results showed that
human leukocytes in the bone marrow, spleen and in the
peripheral blood are infected with dengue virus (Fig. 3). Within
this population we found double positive cells for dengue and B
lymphocytes, dengue and T lymphocytes, and dengue and
monocytes/macrophages. Dengue positive B cells were observed
primarily in the first 3 days p.i. and decreased dramatically by day
4, while dengue positive T cells appeared on day 3 and decreased
to undetectable levels by day 18 p.i., except in blood. Of note was
that the dengue positive monocyte/macrophage subpopulation
presented a double peak distribution, resembling the viremia curve
(Fig. 1A), with the first peak more evident in blood and bone
marrow at days 3 and 6 p.i., respectively, and a second peak on
days 10 and 14 p.i. in spleen. Since monocytes and macrophages
are the main targets for dengue virus in human infections, these
results are especially relevant to validating this model of disease.
We attempted to measure the subpopulation of human dendritic
cells positive for dengue antigen, but, because of the low frequency
of this subpopulation in the lymphocyte gate, accurate analysis was
not possible (data not shown), and further experiments to enrich
this cell population in this mouse model will be necessary.
Figure 1. Humanized mice develop clinical signs as in humans. Groups of mice (n=3) were intradermally inoculated with 9 log10 genome
equivalents of the SE Asian strain K0049 of DEN-2, or with media only for control group, and viremia was measured in sera, at the indicated days post
infection (p.i.) (A, upper panel); each point indicates the mean value of 3 mice and the standard error of the mean (SEM) is indicated by bars above
and below each point. Engraftment levels of experimental groups at each time point are also shown (A, lower panel). Mock-inoculated control
groups were always negative. Clinical signs were measured at the same time points, and the mean values of erythema (B) and fever (C) are shown.
For thrombocytopenia, platelets were measured at day 10 p.i. (D). The statistical significance of the comparisons between infected (white boxes) and
control groups (grey boxes) are shown in the upper portion of each panel.
doi:10.1371/journal.pone.0020762.g001
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patients showed dengue antigen and RNA in different organs or
tissues [15–18]. Jessie et al [17] showed that macrophages, reactive
lymphoid B cells, and peripheral lymphocytes were the major cell
targets. In the present study we found histological evidence of
infected cells in the spleen, particularly in the FLSs; using flow
cytometry analysis, we were able to demonstrate the presence of B
cells in this tissue at early and late stages of infection (days 2–3, and
10 and 14, respectively), in agreement with the autopsy studies. In
addition, our results showing infected human cells in the bone
marrow support previous observations of infected cells in long-
term marrow cultures [19,20] and in the bone marrow of autopsy
samples [17,21,22]. Marrow cell suppression has been postulated
to be involved in the leukopenia and thrombocytopenia observed
in dengue fever patients [23–25]. One proposed mechanism of
leukopenia is the activation of cross-reactive T cells, resulting in
the production of bone marrow-suppressive cytokines. We
observed infected T cells in the bone marrow of our mice that
could have infiltrated in response to the inflammatory process
and/or the infection of local cells, thus supporting such a
mechanism of disease.
Human cytokine and chemokine production in infected,
humanized mice
To evaluate the capacity of the human cells to produce
cytokines and chemokines in response to dengue virus infection in
these mice, and to compare this to the human response, we
measured the levels of human TNF-a, IFN-c, IL-2, sIL-2R, IL-6,
Figure 2. Dengue virus infects human cells in tissues of humanized mice. Morphology of spleen (SP) and bone marrow (BM) of humanized
mice infected with dengue virus were analyzed by H&E staining (A–H). Tissue sections of SP and BM control mice (inoculated with media only) are
shown in A and B, respectively (406magnification), while for infected mice, SP sections are shown in C and D and different aspects of BM are shown
in E–H; C and E–G are at 106, D and H are at 406. Infected human cells were analyzed by double staining with anti-human CD45 (green) and anti-
DEN-2 3H5 Mab (red). Merged images (406) of representative sections of SP and BM are shown in I and M, respectively (day 4 p.i.), J and N (day 10
p.i.), K and O (day 14 p.i.), and L and P (day 18 p.i.). Sections indicated by arrows in J and O are amplified in Q and R, respectively. Negative controls
are shown in S (SP) and T (BM). Results presented here are representative images of 9 independent experiments (n=3) performed at each time point.
doi:10.1371/journal.pone.0020762.g002
Dengue Virus Tropism in Humanized Mice
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20762IL-8, IL-10, MCP-1 and VEGF in the sera of infected and control
mice at different time points. The fluorescently-labeled bead
technology, in the multiplex format used here, allowed us to detect
human cytokines and chemokines in very small volumes of sera
obtained from infected mice. Results are presented as the mean
value from 3 mice, after subtraction of background, which was the
mean of the values in controls. Results showed that all of the
measured cytokines or chemokines were secreted by human cells
during infection, and that values for all peaked on day 8 p.i.
(Fig. 4).
High levels of IFN-c have been associated with severity in
dengue-infected patients [26,27]. This Th1 cytokine is produced
by T cells and induces the production of inflammatory cytokines,
and can activate mononuclear phagocytes (monocytes and
dendritic cells), which could in turn produce other molecules such
as TNF-a and platelet-activating factor, other mediators implicat-
ed in dengue pathogenesis [26,28]. In the humanized mice we
found high levels of IFN-c by day 8 p.i., that could be related to
the increased levels of TNF-a on days 6 and 8 p.i. Another Th1
cytokine is IL-2, a stimulator of cell grow and differentiation,
which targets T and B cells, NK cells, macrophages and
oligodendrocytes; it has been observed that levels of IL-2 along
with other Th1 cytokines are elevated in dengue fever patients
[29]. In humanized mice we found that IL-2 peaked at day 6 p.i.,
decreasing by day 14, and with a slight increase again by day 18.
The soluble Il-2 receptor (sIL-2R) is also considered a marker of
cell activation, and because it binds to soluble IL-2 it could
regulate its action; however, in patients infected with dengue virus,
it has been reported that sIL-2R levels are increased in serum or
plasma [29,30]. In dengue-infected mice we found increased levels
of sIL-2R that peaked on day 8 p.i., similar to the curve observed
for IL-2.
In addition, Th2 cytokines such as IL-10 have been associated
with increased severity in dengue patients. IL-10 is an anti-
inflammatory cytokine produced by monocytes and macrophages
and it down-regulates the production of Th1 cytokines. The IL-10
profile in dengue patients showed low levels in dengue fever cases,
while increased levels were observed in DHF patients [31]. In our
model we observed a peak in IL-10 production by day 8 p.i., but it
was undetectable on days 10–14 and increased again on day 18. In
contrast, IL-6 was observed in low concentrations throughout: it
appears on day 2, slightly increases on day 8, and returns to initial
levels on day 18. This cytokine can act as a pro- and anti-
inflammatory factor, and in dengue patients, increased levels have
been observed in both DF and DHF cases [27,31]. Two
chemokines have been associated with increased severity in
dengue cases: MCP-1 and IL-8 are increased in patients with
DHF [27,32]. MCP-1, along with TNF-a, has been associated
with thrombocytopenia; in our mouse model we observed a
significant decrease in the platelet count at day 10 p.i, which is
Figure 3. Human lymphocytes in mice are infected with dengue virus. Cell homogenates obtained at different time points p.i. from bone
marrow (BM), spleen (SP), and blood (BL) of dengue-infected mice, were analyzed by flow cytometry to identify infected human cells. Cells were
stained against human CD45 (general leukocyte marker), CD19 (B lymphocytes), CD3 (T lymphocytes), CD14 (monocytes/macrophages), and dengue
prM protein. The percent of CD45
+, CD45
+-CD19
+, CD45
+-CD3
+, and CD45
+-CD14
+ infected cells are shown. Values obtained from mock-inoculated
(media only) mouse controls were subtracted from mean values of infected mice; plots are the mean of 3 mice (n=3) at each time point, the SEM is
indicated as bars.
doi:10.1371/journal.pone.0020762.g003
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days 6 and 8 (Fig. 1D and 4, respectively). On the other hand, IL-8
levels in the serum of infected mice were always low, and we have
no explanation for this; other studies have shown that IL-8 is low
in DF patients, while it is consistently higher in DHF cases [27].
Finally, vascular endothelial growth factor (VEGF) seems to play
an important role in the pathogenesis of dengue since it has been
associated with vascular permeability in DHF patients [33,34]; in
the humanized mice we found that VEGF is elevated during the
entire study period, peaking on day 8.
Discussion
After several decades of research, there are important gaps in
our understanding of dengue virus infection in humans and these
gaps have slowed down the development of an effective treatment
for dengue disease. A relevant, cost-effective, and predictable
animal model is necessary to conduct fine and time-detailed
studies in order to decipher the complex immunological
mechanisms involved in dengue fever pathology. Non-human
primates have been used in an attempt to accomplish this goal,
but, outside of economical and ethical concerns, the main
limitation of these models are in their biological relevance,
because of low and transient viremias and the lack of consistent
clinical signs or symptoms (as observed in human patients) [2].
Rodents are a more amenable small animal model of human
diseases, and humanized mice have emerged as a powerful tool to
study infectious disease, including dengue fever [6]. We previously
demonstrated that mice transplanted with human hematopoietic
progenitor cells can support dengue virus replication and develop
clinical signs as occur in human patients [10,11]. Here we
demonstrated that dengue virus replicates in several tissues in the
humanized NOD-scid IL2Rc
null mice, where human cells are
located after transplantation. These results are in agreement with
previous reports where dengue positive cells were found in the
lymph nodes and spleen of human DHF cases [18]. We found that
in addition to monocytes/macrophages, B and T leukocytes
become infected and these infected cells could be detected as early
Figure 4. Humanized mice infected with dengue virus produce cytokines and chemokines. Human cytokines and chemokines (TNF-a,
IFN-c, IL-2, sIL-2R, IL-6, IL-8, IL-10, MCP-1 and VEGF) secreted by humans after dengue infection were measured in the sera of infected, humanized
mice. Sera were obtained at different times p.i. and cytokine/chemokines measured in duplicate. Values for control sera, from mock-inoculated mice,
were subtracted and plots indicate the mean of 3 mice (n=3) at each time point; results were expressed in picograms per mL, with the SEM indicated
as bars.
doi:10.1371/journal.pone.0020762.g004
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marrow, after several days. B lymphocytes have been postulated as
a target cell during virus infection, since dengue virus was
recovered from B cells of PBMCs obtained from dengue patients
generally [35] and from DHF patients specifically [36]; more
recent flow cytometry analysis has shown some evidence for B cell
infection, albeit by elimination of other cell subpopulations from
pediatric patient samples [37]. Also, ex vivo-infected B cells,
obtained from human PBMCs, support dengue virus replication as
evidenced by negative-strand RNA amplification and structural
and non-structural viral antigen detection [38]. Infected B cells
were able to produce IL-6 and TNF-a, and viral replication and
cytokine production were similar in monocytes from the same
PBMCs. In our dengue fever model we observed that both
cytokines are produced in infected mice, and it seems that B cells
could play a role in supporting virus replication in the early stages
of the infection (days 1–2 p.i.), especially in the bone marrow.
Infected monocytes/macrophages are present in lower quantities
early in infection, and are detected in the blood later, possibly
acting as virus-transporting cells to different tissues; this could also
explain the increasing levels of IL-6 and TNF-a in the sera of
infected mice, after day 4 p.i. These results are relevant to natural
human infection since both B cells and monocytes/macrophages
express Fc receptors on their surface [39] and consequently they
are potential targets for antibody-dependent enhancement of
infection [40].
We found that human T cells in the humanized mice also are
permissible for dengue virus infection. Contradictory reports have
been published showing that T cells could either be or not infected
with dengue virus [41–44]. We observed that infected T cells could
be detected in all tissues analyzed by day 3 p.i. and this correlates
with one of these studies. Mentor et al. [43] performed infections
in human T cell lines and reported that dengue-positives cells
could be detected by immunofluorescence staining at 20–60 hrs
p.i., and virus could be detected in the cell culture supernatants by
40 hrs p.i.
We also analyzed liver samples of infected mice and were not
able to detect infected cells although it has been widely reported
that Kupffer cells in human liver could be target cells for dengue
virus replication [16,17,45]. The reason we failed to detect dengue
positive cells in the liver could be related to very low amounts of
human Kupffer cells in humanized mouse liver, and further studies
would be necessary to evaluate this possibility. Another organ in
which we did not detect dengue virus previously is brain, and that
is why we did not test that here [10]. Finally, we were not able to
detect antibodies in infected mice. We attempted to measure total
immunoglobulins (IgA+IgM+IgG) against dengue virus by ELISA
as previously described [11], at days 10, 14 and 18 p.i, but results
were negative in all cases. As we described previously, humanized
mice transplanted with human umbilical cord blood have been
characterized by the low or null production of antibodies, in part
because of the lack of proper cytokine stimulation for B cells to
survive in the murine environment [46,47]. In our studies, we
could speculate that in addition to the lack of the right
microenviroment to expand and survive, B cells could be
eliminated by other immune cells such as macrophages or
cytotoxic T cells, since many of them are infected with dengue
virus; however further experiments are needed to address this
question.
In general we found that human lymphocytes are targets for
dengue replication, and this is in agreement with several reports.
Our results showed that dengue-infected CD45+ cells could be
detected early during infection and among these, human
lymphocytes, monocytes/macrophages and B cells seem to play
a major role in supporting virus replication and dispersion. Other
rodent models have been used to study DF or DHF (reviewed in
[2,48]), but these models require the use of biologically irrelevant
factors, such as inoculation with very high virus doses of lab-
adapted strains and using artificial inoculation routes that impede
reaching robust and consistent conclusions about the complex
mechanisms involved in dengue pathogenesis in humans. Hu-
manized mouse models have thus emerged as a valuable tool to
study dengue fever, using a more systematic and biologically
appropriate approach [9,10,11,49]; however, our model is the
only one to develop clinical signs as in humans. In contrast with
Kuruvilla et al [9], and Jaiswal et al [49], we use only low passage/
non-adapted viruses and we have developed a systematic method
to measure dengue clinical signs. In this study we demonstrated
the presence of dengue antigen in situ by double immunostaining
(in addition to the measurements of viremia in blood and clinical
sings), in order to correlate the infection with a specific cell type, to
overcome the limitations of interpretation based on cell morphol-
ogy alone, as done by Balsitis et al. [18], or by quantification only
of virus particles in tissues such as liver, as reported by Jaiswal et al
[49], which could have been contaminated by infected cells from
the blood. The methodology we developed to produce the
humanized mice consistently produces high engraftment levels
and these mice support dengue virus replication, develop signs of
disease, and infected human cells produce cytokines and
chemokines as observed in humans. This provides evidence for
an innate immune response to dengue virus infection in these
mice. We are currently attempting to improve the adaptive
immune response by adding human cytokines to these mice, to
maintain B and T cell function throughout the infection process,
and to use a more natural route and dose of infection, to get
transmission via mosquito bite. This should allow us to study in
finer detail the complex mechanisms that produce dengue fever,
especially after natural transmission by mosquito bite.
Histopathological studies of dengue patients have been
historically difficult because of many factors, including the fact
that tissue samples are difficult to obtain from patients with dengue
fever only, and that fatal cases are rare and may occur in remote
areas, and it is often difficult to obtain autopsy samples [50]. In
addition, results obtained from samples that were collected,
processed and analyzed in diverse forms, make the interpretation
of pathological findings difficult or inconsistent. The humanized
model presented here represents an efficient way to analyze in a
timely fashion the tropism of dengue virus and the role of specific
cell populations in the development of dengue fever. In summary,
and without ignoring that the humanized mouse is still a model
with limitations, results shown here demonstrate that the
humanized NOD-scid IL2Rc
null mice developed in our laboratory
can be amenable to studying dengue virus infection and
pathogenesis.
Note added in proof: A recent study by Baclig et al., (Southeast
Asian J. Trop. Med. Public Health, 2010, 41(6):1352–1358)
confirmed that many, if not most, of dengue-infected peripheral
blood cells from patients are CD19+ or B cells.
Supporting Information
Figure S1 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 1 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
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each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S2 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 2 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S3 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 3 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S4 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 4 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S5 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 6 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S6 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 8 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S7 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 10 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S8 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 14 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Figure S9 Representative flow cytometry analysis of
dengue infected human cells in the bone marrow of a
humanized mouse (day 18 p.i.). Tissue was collected and
processed as described in materials and methods at the indicated
time point. Cells were stained for human B lymphocytes (CD19),
T lymphocytes (CD3), monocytes/macrophages (CD14), human
leukocytes (CD45), and for dengue virus (E protein). Double
positive cells for each cell subpopulation in the CD45 gate from
each mouse (n=3) were determined and the mean value was
plotted in Figure 3 (see text for details).
(TIF)
Author Contributions
Conceived and designed the experiments: JM RRH. Performed the
experiments: JM. Analyzed the data: JM RRH. Wrote the paper: JM
RRH.
References
1. WHO (2009) Dengue Factsheet. World Health Organization. Available: http://
www.who.int/mediacentre/factsheets/fs117/en/. Accessed 2011 May 24.
2. Bente DA, Rico-Hesse R (2006) Models of dengue virus infection. Drug Discov
Today Dis Models 3: 97–103.
3. Halstead SB (2007) Dengue. Lancet 370: 1644–1652.
4. Rothman AL (2010) Cellular immunology of sequential dengue virus infection
and its role in disease pathogenesis. Curr Top Microbiol Immunol 338: 83–98.
5. Rico-Hesse R (2003) Microevolution and virulence of dengue viruses. Adv Virus
Res 59: 315–341.
6. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational
biomedical research. Nat Rev Immunol 7: 118–130.
7. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, et al. (2007)
Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop
human lymphoid systems and induce long-lasting HIV-1 infection with specific
humoral immune responses. Blood 109: 212–218.
8. Cassetti MC, Durbin A, Harris E, Rico-Hesse R, Roehrig J, et al. (2010) Report
of an NIAID workshop on dengue animal models. Vaccine 28: 4229–4234.
9. Kuruvilla JG, Troyer RM, Devi S, Akkina R (2007) Dengue virus infection and
immune response in humanized RAG2(2/2)gamma(c)(2/2) (RAG-hu) mice.
Virology 369: 143–152.
10. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R (2005) Dengue fever in
humanized NOD/SCID mice. J Virol 79: 13797–13799.
11. Mota J, Rico-Hesse R (2009) Humanized mice show clinical signs of dengue
fever according to infecting virus genotype. J Virol 83: 8638–8645.
12. Cologna R, Rico-Hesse R (2003) American genotype structures decrease dengue
virus output from human monocytes and dendritic cells. J Virol 77: 3929–3938.
Dengue Virus Tropism in Humanized Mice
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e2076213. Wang WK, Sung TL, Tsai YC, Kao CL, Chang SM, et al. (2002) Detection of
dengue virus replication in peripheral blood mononuclear cells from dengue
virus type 2-infected patients by a reverse transcription-real-time PCR assay.
J Clin Microbiol 40: 4472–4478.
14. Armstrong PM, Rico-Hesse R (2001) Differential susceptibility of Aedes aegypti
to infection by the American and Southeast Asian genotypes of dengue type 2
virus. Vector Borne Zoonotic Dis 1: 159–168.
15. Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, et al. (1991)
Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-
embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg
45: 408–417.
16. Miagostovich MP, Ramos RG, Nicol AF, Nogueira RM, Cuzzi-Maya T, et al.
(1997) Retrospective study on dengue fatal cases. Clin Neuropathol 16: 204–208.
17. Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue
virus in naturally infected human tissues, by immunohistochemistry and in situ
hybridization. J Infect Dis 189: 1411–1418.
18. Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, et al. (2009) Tropism of
dengue virus in mice and humans defined by viral nonstructural protein 3-
specific immunostaining. Am J Trop Med Hyg 80: 416–424.
19. Rothwell SW, Putnak R, La Russa VF (1996) Dengue-2 virus infection of human
bone marrow: characterization of dengue-2 antigen-positive stromal cells.
Am J Trop Med Hyg 54: 503–510.
20. Nakao S, Lai CJ, Young NS (1989) Dengue virus, a flavivirus, propagates in
human bone marrow progenitors and hematopoietic cell lines. Blood 74:
1235–1240.
21. Nisalak A, Halstead SB, Singharaj P, Udomsakdi S, Nye SW, et al. (1970)
Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic
studies of fatal disease. Yale J Biol Med 42: 293–310.
22. Guzman MG, Alvarez M, Rodriguez R, Rosario D, Vazquez S, et al. (1999)
Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 3: 130–135.
23. La Russa VF, Innis BL (1995) Mechanisms of dengue virus-induced bone
marrow suppression. Baillieres Clin Haematol 8: 249–270.
24. Bierman HR, Nelson ER (1965) Hematodepressive Virus Diseases of Thailand.
Ann Intern Med 62: 867–884.
25. Lin SF, Liu HW, Chang CS, Yen JH, Chen TP (1989) [Hematological aspects of
dengue fever]. Gaoxiong Yi Xue Ke Xue Za Zhi 5: 12–16.
26. Kurane I, Rothman AL, Livingston PG, Green S, Gagnon SJ, et al. (1994)
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock
syndrome. Arch Virol Suppl 9: 59–64.
27. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, et al.
(2010) Clinical findings and pro-inflammatory cytokines in dengue patients in
Western India: a facility-based study. PLoS One 5: e8709.
28. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al.
(1999) Elevated plasma interleukin-10 levels in acute dengue correlate with
disease severity. J Med Virol 59: 329–334.
29. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, et al. (1991)
Activation of T lymphocytes in dengue virus infections. High levels of soluble
interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-
gamma in sera of children with dengue. J Clin Invest 88: 1473–1480.
30. Valero N, Larreal Y, Espina LM, Reyes I, Maldonado M, et al. (2008) Elevated
levels of interleukin-2 receptor and intercellular adhesion molecule 1 in sera
from a venezuelan cohort of patients with dengue. Arch Virol 153: 199–203.
31. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine
cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS
Immunol Med Microbiol 28: 183–188.
32. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, et al. (2006) MCP-1, a highly
expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome
patients, may cause permeability change, possibly through reduced tight
junctions of vascular endothelium cells. J Gen Virol 87: 3623–3630.
33. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH,
et al. (2007) Virus-induced decline in soluble vascular endothelial growth
receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.
J Virol 81: 1592–1600.
34. Seet RC, Chow AW, Quek AM, Chan YH, Lim EC (2009) Relationship
between circulating vascular endothelial growth factor and its soluble receptors
in adults with dengue virus infection: a case-control study. Int J Infect Dis 13:
e248–253.
35. King AD, Nisalak A, Kalayanrooj S, Myint KS, Pattanapanyasat K, et al. (1999)
B cells are the principal circulating mononuclear cells infected by dengue virus.
Southeast Asian J Trop Med Public Health 30: 718–728.
36. Boonpucknavig S, Bhamarapravati N, Nimmannitya S, Phalavadhtana A,
Siripont J (1976) Immunofluorescent staining of the surfaces of lymphocytes in
suspension from patients with dengue hemorrhagic fever. Am J Pathol 85:
37–48.
37. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, et al. (2008)
Phenotyping of peripheral blood mononuclear cells during acute dengue illness
demonstrates infection and increased activation of monocytes in severe cases
compared to classic dengue fever. Virology 376: 429–435.
38. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, et al. (2002) Virus replication and
cytokine production in dengue virus-infected human B lymphocytes. J Virol 76:
12242–12249.
39. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:
275–290.
40. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM (2010)
Intrinsic antibody-dependent enhancement of microbial infection in macro-
phages: disease regulation by immune complexes. Lancet Infect Dis 10:
712–722.
41. Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, et al. (2008) Monocytes,
but not T or B cells, are the principal target cells for dengue virus (DV) infection
among human peripheral blood mononuclear cells. J Med Virol 80: 134–146.
42. Kurane I, Kontny U, Janus J, Ennis FA (1990) Dengue-2 virus infection of
human mononuclear cell lines and establishment of persistent infections. Arch
Virol 110: 91–101.
43. Mentor NA, Kurane I (1997) Dengue virus infection of human T lymphocytes.
Acta Virol 41: 175–176.
44. Blackley S, Kou Z, Chen H, Quinn M, Rose RC, et al. (2007) Primary human
splenic macrophages, but not T or B cells, are the principal target cells for
dengue virus infection in vitro. J Virol 81: 13325–13334.
45. Huerre MR, Lan NT, Marianneau P, Hue NB, Khun H, et al. (2001) Liver
histopathology and biological correlates in five cases of fatal dengue fever in
Vietnamese children. Virchows Arch 438: 107–115.
46. Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, et al. (2008)
Human BLyS facilitates engraftment of human PBL derived B cells in
immunodeficient mice. PLoS One 3: e3192.
47. Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, et al. (2010) Parameters
for establishing humanized mouse models to study human immunity: analysis of
human hematopoietic stem cell engraftment in three immunodeficient strains of
mice bearing the IL2rgamma(null) mutation. Clin Immunol 135: 84–98.
48. Yauch LE, Shresta S (2008) Mouse models of dengue virus infection and disease.
Antiviral Res 80: 87–93.
49. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, et al. (2009) Dengue
virus infection and virus-specific HLA-A2 restricted immune responses in
humanized NOD-scid IL2rgammanull mice. PLoS One 4: e7251.
50. Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an
integrated view. Clin Microbiol Rev 22: 564–581.
Dengue Virus Tropism in Humanized Mice
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e20762